ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Issues Update on Mortality Risk With Paclitaxel-Coated Products drugs
March 19, 2019?A preliminary analysis has revealed a "potentially concerning signal" of increased long-term mortality risk with paclitaxel-coated products indicated for peripheral arterial disease (PAD), according to a March 15 update from the U.S. Food and Drug Admini
Pharma Sources Insight July 2025
